Usher Syndrome Type 2 Market Poised for Growth with Advancements in RNA and Gene-Based Therapies | DelveInsight

The Usher Syndrome Type 2 market is poised for significant growth and transformation, driven by increasing disease awareness, rising healthcare spending globally, and a robust pipeline of emerging therapeutic candidates targeting this rare genetic disorder that affects both hearing and

Read Full Article →